Cited by 1,040Menopause: Health Impacts and TreatmentsLipoproteins and Cardiovascular HealthHormonal and reproductive studies

Menopause and Risk Factors for Coronary Heart Disease

Matthews, Karen A., Meilahn, Elaine, Kuller, Lewis H., Kelsey, Sheryl F., Caggiula, Arlene W., Wing, Rena R.·1989·New England Journal of Medicine

Abstract

Postmenopausal women are believed to have a higher risk of coronary artery disease than premenopausal women. In this study, we prospectively determined changes in coronary risk factors that were attributable to natural menopause in 541 healthy, initially premenopausal women 42 to 50 years of age. After approximately 2 1/2 years, 69 women had spontaneously stopped menstruating for at least 12 months, and 32 women had stopped natural menstruation and received hormone-replacement therapy for a period of at least 12 months. An equal number of age-matched premenopausal women in the study group served as controls. In women who had a natural menopause and did not receive hormone-replacement therapy, serum levels of high-density lipoprotein (HDL) cholesterol declined as compared with those of premenopausal controls (-0.09 vs. 0.00 mmol per liter; P = 0.01), and levels of low-density lipoprotein (LDL) cholesterol increased (+0.31 vs. +0.14 mmol per liter; P = 0.04). In menopausal women who received hormone-replacement therapy, HDL and LDL cholesterol levels did not change, but the levels of triglycerides (+0.42 vs. -0.04 mmol per liter; P less than 0.001), apolipoprotein A-I (+0.18 vs. +0.03 g per liter; P less than 0.01), and apolipoprotein A-II (+0.05 vs. -0.03 g per liter; P less than 0.05) increased as compared with premenopausal controls. Natural menopause did not affect blood pressure, plasma glucose or insulin levels, body weight, the total number of kilojoules consumed in the diet, or the total number of kilojoules expended in physical activity. These results suggest that a natural menopause has an unfavorable effect on lipid metabolism, which may contribute to an increase in the risk of coronary disease. Hormone-replacement therapy may prevent some of these changes.

Integrity signals

Registry

Crossref · 10.1056/nejm198909073211004

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Matthews, K. A., Meilahn, E., Kuller, L. H., Kelsey, S. F., Caggiula, A. W., & Wing, R. R.
Affiliations
University of Pittsburgh (US)
Venue
New England Journal of Medicine
Published
1989-09-07
Volume
321
Issue
10
Pages
641-646
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W1974580748
Cited by
1,040
References
24
Citations by year
2026: 10 · 2025: 11 · 2024: 11 · 2023: 19 · 2022: 22 · 2021: 33 · 2020: 18 · 2019: 17 · 2018: 20 · 2017: 18 · 2016: 22 · 2015: 24 · 2014: 24 · 2013: 23 · 2012: 27
FWCI
18.54
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Heart, Lung, and Blood Institute (HL-28266)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords
menopause, coronary heart disease risk, coronary risk factors, hormone replacement therapy, lipid metabolism, HDL cholesterol, LDL cholesterol, triglycerides, apolipoprotein A-I, apolipoprotein A-II, postmenopausal women, premenopausal women, blood pressure, insulin
MeSH terms
Apolipoproteins A, Blood Glucose, Coronary Disease, Estrogens, Female, Humans, Insulin, Cholesterol, HDL, Cholesterol, LDL, Longitudinal Studies, Menopause, Middle Aged, Progestins, Risk Factors, Triglycerides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review